A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
暂无分享，去创建一个
H. Eguchi | Y. Doki | M. Mori | T. Mizushima | Hirofumi Yamamoto | D. Sakai | T. Kudo | T. Satoh | N. Miyoshi | K. Murata | M. Uemura | Y. Kagawa | J. Hasegawa | M. Ikenaga | Takeshi Kato | M. Tei | M. Imasato | K. Nakata | H. Takahashi | Aya Kato | Toru Ohtsuru | A. Kato